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Objectives: Mortality from abdominal abscesses ranges from 30% in treated cases
up to 80% to 100% in patients with undrained or nonoperated abscesses. Various
computed tomographic (CT) imaging features have been suggested to indicate in-
fection of postoperative abdominal fluid collections; however, features are
nonspecific and substantial overlap between infected and noninfected collections
exists. The purpose of this study was to develop and validate a scoring system on
the basis of CT imaging findings as well as laboratory and clinical parameters for
distinguishing infected from noninfected abdominal fluid collections after surgery.
Materials and Methods: The score developmental cohort included 100 con-
secutive patients (69 men, 31 women; mean age, 58 T 17 years) who underwent
portal-venous phase CT within 24 hours before CT-guided intervention of
postoperative abdominal fluid collections. Imaging features included attenua-
tion (Hounsfield unit [HU]), volume, wall enhancement and thickness, fat
stranding, as well as entrapped gas of fluid collections. Laboratory and clinical
parameters included diabetes, intake of immunosuppressive drugs, body tem-
perature, C-reactive protein, and leukocyte blood cell count. The score was
validated in a separate cohort of 30 consecutive patients (17 men, 13 women;
mean age, 51 T 15 years) with postoperative abdominal fluid collections.
Microbiologic analysis from fluid samples served as the standard of reference.
Results: Diabetes, body temperature, C-reactive protein, attenuation of the fluid
collection (in HUs), wall enhancement and thickness of the wall, adjacent fat
stranding, as well as entrapped gas within the fluid collection were significantly
different between infected and noninfected collections (P G 0.001). Multiple lo-
gistic regression analysis revealed diabetes, C-reactive protein, attenuation of the
fluid collection (in HUs), as well as entrapped gas as significant independent
predictors of infection (P G 0.001) and thus was selected for constructing a
scoring system from 0 to 10 (diabetes: 2 points; C-reactive protein, Q100 mg/L: 1
point; attenuation of fluid collection, Q20 HU: 4 points; entrapped gas: 3 points).
The model was well calibrated (Hosmer-Lemeshow test, P = 0.36). In the vali-
dation cohort, scores of 2 or lower had a 90% (95% confidence interval [CI],
56%Y100%) negative predictive value, scores of 3 or higher had an 80% (95%CI,
56%Y94%) positive predictive value, and scores of 6 or higher a 100% (95% CI,
74%Y100%) positive predictive value for diagnosing infected fluid collections.
Receiver operating characteristic analysis revealed an area under the curve of 0.96
(95% CI, 0.88Y1.00) for the score.
Conclusions: We introduce an accurate scoring system including quantitative
radiologic, laboratory, and clinical parameters for distinguishing infected from
noninfected fluid collections after abdominal surgery.
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A bdominal fluid collections are common after surgery, with areported prevalence up to 64% in imaging studies.1 This holds
true for various types of abdominal surgery, primarily including
gastric and bowel surgery but also procedures such as partial hepa-
tectomy, pancreatectomy, and biliary tract surgery. Depending on their
content, fluid collections can be divided into seroma, lymphocele, he-
matoma, or bilioma.2,3 Irrespective of their content, all these fluid col-
lections can get infected, leading to abscess formation. When there is
suspicion for abscess formation after surgery, radiologists and surgeons
are prompted to consider the underlying etiology of infection such as
anastomotic or bile leakage and fistula. In addition, infected abdominal
fluid collections often need to be treated, either interventionally or
surgically. Thus, the accurate distinction between infected and
noninfected abdominal fluid collections after surgery is mandatory to
avoid unnecessary treatment.
The differentiation between infected and noninfected fluid
collections is important because it influences treatment algorithms
toward a more aggressive approach, which, besides an antibiotic
regimen, includes percutaneous or surgical drainage.4 Mortality from
infected abdominal fluid collections ranges from 30% in treated cases
up to 80% to 100% in patients with undrained and nonoperated ab-
scesses,5 indicating the clinical relevance of an accurate diagnosis in
the postoperative setting.
The standard of reference for the diagnosis of infected fluid
collections is actually microbiological analysis of fluid samples.
Samples are analyzed through microscopic examination and Gram
staining. In addition, agar plates are used as media for culturing
microorganisms. Infection is considered absent if microscopic and
Gram stain as well as cultures are negative.6
Although percutaneous drainage of postoperative abdominal fluid
collections is usually effective with a treatment success of 90% or higher,
a nonnegligible procedure-associated complication rate remains, includ-
ing septicemia, hemorrhage, and death.7Y10 Moreover, up to one third of
fluid collections cannot be drained completely.11,12 Finally, noninfected
fluid collections can be an incidental finding after surgery without the
need for any treatment, potentially resorbing spontaneously.13
Computed tomography (CT) represents the most popular imag-
ing modality for the identification and characterization of postoperative
abdominal fluid collections.3,14 Fluid attenuation measurements, en-
capsulation, stranding of the surrounding fat, and the presence of gas
within the collection had been proposed as being helpful for differen-
tiating infected from noninfected collections. However, these CT im-
aging parameters are nonspecific and a substantial overlap between
infected and noninfected fluid collections exists.3,15,16
The purpose of this study was to develop and validate a scoring
system incorporating CT imaging findings as well as laboratory and
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clinical parameters for discriminating infected from noninfected ab-
dominal fluid collections after abdominal surgery.
MATERIALS AND METHODS
Study Population
The retrospective study was approved by the hospital’s ethics
committee. Written informed consent requirement was waived be-
cause no CTwas merely performed for the purpose of the study.
Between December 2009 and November 2011, a total of 130
consecutive patients (82 men, 48 women; mean age, 58 T 15 years)
were referred to our radiology department for CT-guided percutane-
ous drainage of an intraperitoneal and retroperitoneal fluid collection
after surgery. Inclusion criteria for study enrollment were previous
abdominal surgery (including both laparoscopic and open surgery)
and an abdominopelvic CT scan obtained in the portal-venous phase
of enhancement within 24 hours before CT-guided intervention.
Further inclusion criteria were as follows: microbiologic analysis of
the tapped fluid samples, body temperature measurements, and blood
sample including white blood cell counts and C-reactive protein
within 6 hours before CT-guided intervention.
Exclusion criteria were abdominal fluid collections in solid
abdominal organs and those with 1 or more missing laboratory pa-
rameters or body temperature measurements (n = 21), CT scan
without contrast media or CT scan not obtained within 24 hours
before CT-guided percutaneous intervention (n = 7), as well as
missing microbiological results (n = 2). Thus, we included a total of
100 patients (69 men, 31 women; mean age 57 T 15 years) in the first
part of the study (Fig. 1; Table 1), which was aimed at the develop-
ment of the scoring system.
The second part of the study was planned for validating the
scoring system. This was performed in a separate cohort of 30 con-
secutive patients (17 men, 13 women; mean age, 51 T 15 years) with
postoperative abdominal fluid collections referred to our department
between December 2011 and June 2012 (Table 1). Similar to the 100
patients in the first study part, all these 30 patients underwent a
contrast-enhanced CT acquired during the portal-venous phase within
24 hours before CT-guided percutaneous intervention.
Review of Medical Records and Laboratory Findings
One radiologist (R1, with 2 years of experience in abdominal
radiology) reviewed the medical records of all patients in the
hospital’s electronic medical records system and extracted the fol-
lowing data: age and sex, underlying disease, type of surgery, pres-
ence of diabetes (defined according to the American Diabetes
Association guidelines17), time interval between abdominal surgery
and CT-guided intervention, actual intake of immunosuppressive
drugs (glucocorticoids, cytostatics, antibodies against lymphocytes,
drugs acting on immunophilins, interferons, tumor necrosis factor
binding proteins), antibiotics, body temperature and blood sample
including C-reactive protein, as well as white blood cell counts within
6 hours before percutaneous drainage.
CT Imaging Protocol
All CT studies were performed on a 64-slice CT machine
(Definition AS; Siemens Healthcare). In each patient, 90 mL of
iopromide (Ultravist 300, 300 mg/mL; Bayer Schering Pharma) were
injected at a flow rate of 2.6 mL/s, followed by 40 mL of saline solution
at the same flow rate. After a delay of 70 seconds, CT data acquisition
was started in the portal-venous phase of enhancement. Automated tube
current modulation (CareDose4D; Siemens) was used, with a reference
tube current-time product of 150 reference mAs. The other CT pa-
rameters were as follows: detector collimation, 32  0.6mm; slice ac-
quisition, 64 0.6 mm by means of a z-flying focal spot; tube voltage,
120 kV(p); pitch, 1.2; and rotation time, 0.33 seconds.
Images were reconstructed using a medium-smooth soft tissue
convolution kernel at a slice thickness of 2 mm and an increment of
1.5 mm.
CT Image Analysis
Computed tomographic data analysis was performed by 2 inde-
pendent readers (R2, with 5 years and R3, with 9 years of experience in
abdominal radiology). Both readers were blinded to the patients’ his-
tory, laboratory, and microbiological findings as well as to the results of
each other. They qualitatively and quantitatively assessed CT imagesFIGURE 1. Flow chart of the score developmental study cohort.
TABLE 1. Demographic and Clinical Variables of Patients With
Postoperative Abdominal Fluid Collections
Score Development
Cohort (n = 100)
Score Validation
Cohort (n = 30)
Age, y 57 T 15 (17Y87) 51 T 15 (21Y77)
Sex, male/female 69/31 17/13
Body mass index, kg/m2 27.2 T 5.2 (15.1Y41.5) 26.9 T 5.1 (17.1Y38.7)
Underlying disease
Carcinoma 57 16
Infection 24 8
Trauma 6 3
Vascular 7 2
Others 6 1
Surgery before drainage
Gastrointestinal 34 10
Liver, gallbladder,
and spleen
47 14
Peritoneal lavage/
exploration
9 3
Urogenital 5 1
Pancreas, kidney,
or liver transplantation
5 2
Age and body mass index expressed as mean T standard deviation (range).
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using the picture archiving and communication system (PACS; IMPAX
5.3, version 6; Agfa, Moertel, Belgium) of the hospital. Multiplanar
reformations and arbitrary window width and level settings were
allowed. The following parameters were assessed:
- The CTattenuation (in Hounsfield units [HUs]) in a region of interest
(average size of approximately 200 mm2) placed within the fluid
collection while avoiding partial volume effects from the wall;
- The volume of the encapsulated fluid collection determined by the
ABC/2 formula, whereas Awas the greatest transverse diameter,
B was the transverse diameter perpendicular to A, and C was the
number of CT slices including the fluid collection multiplied by
the effective slice thickness;
- Presence or absence of hypervascular reparative tissue encapsulating
the fluid collection, resulting in wall enhancement, defined as a
hyperdense rim around the fluid collection;
- Wall thickness (in millimeters) using the electronic caliper tool provided
by the PACS software;
- Presence or absence of fat stranding surrounding the fluid collection; and
- Presence or absence of entrapped gas within the collection.
Diagnosis of Infected andNoninfected Fluid Collections
Immediately after CT-guided intervention, at least 5 mL of the
drained fluid was sent for microbiological analysis. According to
current standards,6 fluid was considered infected if leukocytes and
bacteria were detected on the Gram stain and/or the culture was
positive (bacteria or fungi). Otherwise, the fluid collection was de-
clared as being negative (ie, noninfected).
Statistical Analysis
Continuous variables were expressed as means T standard
deviations and ranges or as medians and ranges. Categorical variables
were expressed as frequencies with percentages.
Interreader agreements for wall enhancement, fat stranding, and
gas entrapment were assessed with the Cohen J statistics (J 9 0.81,
excellent agreement; J = 0.61Y0.80, good agreement; J = 0.41Y0.60,
moderate agreement; J = 0.21Y0.40, fair agreement; and J G 0.20, poor
agreement). Interreader agreements for attenuation, fluid volume, and
wall thickness were assessed with intraclass correlation coefficients
(ICCs).
Infected and noninfected fluid collections were compared using
theMann-WhitneyU test for the continuous variables and the W2 test for
the categorical variables. The W2 test was also used for testing the re-
lationship between infection as underlying disease necessitating surgery
and postoperative infection. Receiver operating characteristic (ROC)
analysis with calculation of the area under the curve (AUC) with 95%
confidence intervals (CIs) was performed for the parameters showing
2-tailed P values below 0.05 on the univariate analysis.
All these variables were then included into multiple logistic
regression analysis. For the multiple regression analysis, the variables
were logarithmically transformed (time interval between abdominal
surgery and CT-guided intervention and fluid volume), dichotomized
at the median (body temperature, C-reactive protein) or visually
binned, as appropriate.
Then, the bestglm package18 in R (version 2.15.0) was used for
model selection with Bayesian information criterion. Of the top 3models,
we selected the one being most appropriate for daily clinical use.
We then developed a score by rounding the regression co-
efficients. The ROC analysis reporting the AUC with 95% CI was
performed to illustrate the predictive performance of all models.
Model calibration was assessed using the Hosmer-Lemeshow test.
Validation of the score was performed in a separate validation
set reporting positive (PPV) and negative (NPV) predictive values
with 95% CI.
Except for model selection (see above), all analyses were
performed using IBM Statistical Package for the Social Sciences
Statistics version 20.0 (SPSS Inc, Chicago, IL). Statistical signifi-
cance was inferred at a P value below 0.05.
RESULTS
CT Image Analysis
Attenuation (ICC, 0.874), volume (ICC, 0.967), and wall
thickness (ICC, 0.933) of fluid collections showed a high agreement
between the readers. The interreader agreement for wall enhancement
(J = 0.83; 95% CI, 0.72Y0.94), fat stranding (J = 0.89; 95% CI,
TABLE 2. Demographics, Laboratory Results, and CT Imaging Findings in the Score Developmental Cohort (n = 100)
Noninfected Fluid Collections (n = 40) Infected Fluid Collections (n = 60) P*
Age, y 58 T 17 (17Y87) 57 T 14 (21Y79) 0.53
Sex, male/female 30/10 39/21 0.29
Diabetes 6 (15%) 26 (43%) 0.003
Time interval†, d 86 T 26 (1Y163) 68 T 14 (1Y175) 0.74
Immunosuppressive drugs 7 (18%) 8 (13%) 0.57
Antibiotics 24 (60%) 38 (63%) 0.43
Body temperature, -C 37 T 0.7 (36Y39) 38 T 0.7 (36Y39) 0.02
C-reactive protein, mg/L 106 T 80 (2Y276) 155 T 103 (11Y415) 0.02
Leukocytes, 103/KL 10.6 T 5.9 (4.7Y28.4) 12.5 T 5.8 (2.5Y28.0) 0.06
Attenuation, HU 8 T 6 (0.1Y26) 17 T 9 (2Y37) G0.001
Fluid volume, cm3 227 T 227 (9Y1200) 251 T 452 (5Y1600) 0.1
Wall enhancement 13 (33%) 50 (83%) G0.001
Wall thickness, mm 1.9 T 1.1 (1Y5) 2.9 T 1.2 (1Y7) G0.001
Fat stranding 11 (28%) 34 (57%) G0.001
Entrapped gas 3 (8%) 32 (53%) G0.001
Data are expressed as mean T standard deviation (range) or frequencies with percentages.
*Mann-Whitney U Test and Pearson W2 test.
†Time interval between surgery and percutaneous drainage.
CT indicates computed tomography; HU, Hounsfield units.
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0.73Y1.00), and entrapped gas (J = 0.94; 95% CI, 0.94Y0.98) was
excellent. Because of the high agreement between the readers, the
results from 1 reader (R2) were used for further analysis.
Univariate Analysis
The results of the univariate analysis are summarized in Table 2.
Diabetes, body temperature, C-reactive protein, CT attenuation, wall
enhancement, wall thickness, fat stranding, and entrapped gas were
significantly different between the infected and noninfected collections
(all P G 0.001). The highest AUC was found for CT attenuation of the
fluid collections (0.80; 95% CI, 0.72Y0.89) (Fig. 2). There was no
significant relationship between the presence or absence of underlying
infection necessitating surgery and postoperative infection (P = 0.64).
Model Selection
The use of the bestglm command gave rise to different models.
From these, we evaluated the top 3 models with the highest AUC. The
first one included diabetes, body temperature, CT attenuation, and
entrapped gas (AUC, 0.90; 95% CI, 0.84Y0.96); the second one in-
cluded diabetes, CTattenuation, and gas entrapment (AUC, 0.89; 95%
CI, 0.82Y0.96); and the third model included diabetes, C-reactive
protein level, HU value, and gas entrapment (AUC, 0.90; 95% CI,
0.84Y0.97).
Because body temperature had a very small standard deviation
(0.73) and is influenced by many different factors (eg, fever-reducing
drugs, time of measurement throughout the day, type of measure-
ment), we skipped the first model including body temperature having
the same AUC as that of model 3. Finally, we chose model 3, which
was well calibrated (Hosmer-Lemeshow test, P = 0.36) and which
discriminated well between the infected and noninfected abdominal
fluid collections with an AUC of 0.90 (95% CI, 0.84Y0.97).
Development of the Score
A numerical score was derived from the regression co-
efficients of the 4 independently significant variables of model 3. The
cutoff for the CT attenuation of the fluid was chosen through visual
binning (Fig. 3). The cutoff for the C-reactive protein serum level was
chosen as the median (113 mg/L). Because the AUC of C-reactive
protein was relatively low (0.64), we chose 100 mg/L as a cutoff
value for a more easy clinical applicability (reference range of
C-reactive protein in our laboratory is G5 mg/L).
The score of each patient was calculated by totaling the scores
of each independent variable (Table 3). Using the score in the de-
velopment cohort, we stratified the patients into 2 groups through
visual binning: low (score, e2) and high (score, Q3) probability of
having an infected abdominal fluid collection (Fig. 4). In the score
developmental cohort, scores of 3 or higher had a PPVof 84% (95%
CI, 73%Y92%) and a score of 6 or higher had a PPVof 94% (95% CI,
80%Y99%). Scores of 2 or lower had an NPV of 91% (95% CI,
75%Y98%) for the diagnosis of the infected and noninfected fluid
collections, respectively (Table 4).
Validation of the Score
The model validation was performed using a cohort of
30 consecutive patients, in whom complete data to calculate the score
were available. In 20 patients with a score of 3 or higher, 4 fluid
collections were noninfected (4 false positives). In 10 patients with
a score of 2 or lower, 1 collection was infected (1 false negative)
(Table 4). Scores of 3 or higher had an 80% (95% CI, 56%Y94%) and
scores of 6 or higher had a 100% (95% CI, 74Y100%) PPV for di-
agnosing infected fluid collections. The NPVof scores of 2 or lower
was 90% (95% CI, 56%Y100%). The ROC analysis revealed an AUC
of 0.96 (95% CI, 0.88Y1.00) for the scoring system. Representative
image examples of the patients with infected and noninfected fluid
collections are provided in Figures 5 and 6.
DISCUSSION
Percutaneous catheter drainage is the treatment of choice for
potentially infected abdominal fluid collections, if there is no evident
underlying etiology requiring immediate surgery (such as anastomotic
FIGURE 2. Receiver operating characteristic curves for accuracy
for radiologic, laboratory, and clinical parameters being
significant in the univariate analysis for predicting infected fluid
collections in 100 patients. Legend represents AUC with 95%
confidence intervals in brackets.
FIGURE 3. Cutoff points for HUs were chosen through visual
binning (HU G10 = 0 points; 10 e HU G20 = 2 points; HU Q20 =
4 points).
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leakage).19,20 In our cohort with a total of 130 patients, however, 40%
of drained fluid collections were not infected, which is comparable with
the number reported in previous studies.11,15,21 Thus, an intervention
aiming at draining infection would not have been necessary in these
patients. On the basis of this clinical experience, we developed and
validated a score for a better distinction between infected and
noninfected abdominal fluid collections after surgery using quantitative
information from imaging, clinical, and laboratory data.
For the development of the score, we analyzed 5 clinical/laboratory
parameters: presence of diabetes, intake of immunosuppressive drugs,
body temperature, C-reactive protein serum level, and leukocyte blood
cell counts. Previous studies demonstrated a high correlation between
diabetes and postoperative abdominal abscesses and infections after
surgery.22,23 This is in line with our results indicating that the presence
of diabetes is a risk factor for infection of an abdominal fluid collection
after surgery.
Patients receiving immunosuppressive medication such as
glucocorticoids, cytostatics, antibodies against lymphocytes, drugs
acting on immunophilins, interferons, and tumor necrosis factor
binding proteins can develop severe lymphopenia, which is deemed
to be a risk factor for infections.24 Our results, however, showed no
relationship between the intake of immunosuppressive drugs and
postoperative infected fluid collections, similar to a recent study by
Bafford et al25 in patients with Crohn disease in whom intake of
immunosuppressive medication was not associated with an increase
in postoperative infections.
In our score developmental cohort, body temperature showed
good predictive capabilities regarding the differentiation between
infected and noninfected fluid collections. However, because of its
small standard deviation (0.73); many potential measurement biases
such as intake of fever-reducing drugs, circadian undulation of body
temperature, type and location of measurement; and its unspecific
character being not necessarily related to infection,26 we did not in-
clude body temperature in our scoring system.
FIGURE 4. Histogram of the score distribution in the 100
patients of the score developmental cohort. On the basis of this
graph, we stratified patients into 2 groups: scores 0 to 2, low
probability; scores 3 to 10, high probability of having an
infected fluid collection.
TABLE 4. Performance of the Scoring System in the Score
Developmental and in the Score Validation Cohorts
Noninfected Fluid
Collections
Infected Fluid
Collections
Score developmental cohort (n = 40) (n = 60)
Low probability (score, 0Y2) 29 (73%) 3 (5%)
High probability (3Y10) 11 (27%) 57 (95%)
Score validation cohort (n = 13) (n = 17)
Low probability (score, 0Y2) 9 (69%) 1 (6%)
High probability (3Y10) 4 (31%) 16 (94%)
TABLE 3. Final Model Using Parameters Found to be
Independently Predictive of Infected Abdominal Fluid Collections
Based on Multiple Regression Analysis
A (Regression Coefficient) Points
Diabetes
No 0 0
Yes 1.7 2
C-reactive protein, mg/L
G100 0 0
Q100 0.9 1
Gas entrapment
No 0 0
Yes 2.7 3
CT attenuation, HU
G10 0 0
10 e HU G 20 1.7 2
Q20 3.4 4
Minimum total score 0
Maximum total score 10
HU indicates Hounsfield units.
FIGURE 5. Contrast-enhanced abdominal CT scan of a
43-year-old man 9 days after surgical treatment of duodenal
perforation showing an encapsulated fluid collection with gas
entrapment adjacent to the left liver lobe (a). The
corresponding score in this patient was 8 (diabetes present;
C-reactive protein, 254 mg/L; gas entrapment present; CT
attenuation of the fluid collection, 16 HU), indicating a high
probability of infection. Percutaneous puncture and drainage
were performed, and microbiologic testing revealed infection
of the fluid collection with Escherichia coli.
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C-reactive protein and leukocyte blood cell counts are com-
monly used in clinical routine for determining the presence or ab-
sence of infection. The specificity of C-reactive protein is limited in
patients after surgery because it might be increased postoperatively
also in the absence of infection. In our study group, C-reactive pro-
tein was significantly higher in infected as compared with
noninfected fluid collections and was an independent predictor of
infection based on the multiple regression analysis. Thus, we in-
cluded this laboratory parameter with a cutoff value of 100 mg/L, for
a more easy clinical applicability, into the scoring system.
We included into our analysis various CT imaging features
such as wall enhancement and wall thickness, entrapped gas, sur-
rounding fat stranding, and attenuation of the fluid collection. The
presence and enhancement of the wall surrounding fluid collections
are related to fibrin, which represents a defense mechanism for lo-
calizing and limiting peritoneal infections.27 In our population, wall
thickness and presence or absence of wall enhancement distinguished
well infected from noninfected fluid collections. However, both pa-
rameters were not included in the top 3 models from the multiple
logistic regression analysis and thus were not implemented in the
scoring system.
The presence of gas within a fluid collection has been repetitively
shown to be a good predictor for infected fluid collections.21,28 This was
also confirmed in our study both in the univariate and multiple regres-
sion analyses. Thus, we included this imaging feature into the score.
Fat stranding is an unspecific sign of inflammation occurring
also in other conditions such as ischemia, bowel perforation, and,
after surgery, in the absence of infection.29 This is also reflected in
our study population in which 28% of sterile fluid collections showed
adjacent fat stranding. Whereas fat stranding showed in the univariate
analysis a significant difference between infected and noninfected
fluid collections, the parameter was not significant in the multiple
regression analysis. Thus, fat stranding was not implemented as an
imaging feature into the final score.
The underlying hypothesis of measuring attenuation of fluid
collections is that debris in an infected fluid collection leads to higher
CT attenuation.3 Previous studies were contradictory regarding the
value of attenuation measurements. Whereas earlier studies reported
near-water attenuation of infected collections,15,28 a recent study
showed attenuation values higher than 20 HU when infection was
present.21 In our patients, attenuation measurements allowed dis-
criminating well infected from noninfected collections, with only
2 patients with noninfected collections having attenuation values
higher than 20 HU. Hemorrhage into the fluid cavity might be a
reason for higher attenuation values of these noninfected collections.
Only few prior studies have combined more than 1 imaging fea-
ture for improving the accuracy of diagnosing infected collections.
Jaques et al16 reviewed CT examinations of 71 patients, recording
the features of abscesswall, septation, gas/fluid level, presence of a sharp
margin, and presence of gas bubbles. In their study, 69% of patients had
1 or more and only 6% had 3 of the features mentioned previously. Allen
et al21 showed in their study that gas entrapment and fluid attenuation
were significant predictors of infection. However, their good sensitivity
(83%) was associated with a low specificity (39%).
We used a different approach by developing a scoring system
with inclusion of clinical and laboratory parameters as well and by
performing a multiple logistic regression analysis. This approach
results in a different weighting of the various imaging, clinical, and
laboratory findings based on their individual regression coefficients
and, hence, in different points in the scoring system for each pa-
rameter. By doing so, we could demonstrate in our validation cohort
a high accuracy of the score (AUC of 0.96), a PPVof 80% for scores
of 3 or higher, a PPVof 100% for scores of 6 or higher, and an NPV
of 90% for scores of 2 or lower. Considering both development and
validation cohorts, 42 of the 130 patients had scores of 2 or lower,
indicating low probability of infection. This means that 42 in-
terventions would have been avoided when relying on the score. Of
these 42 fluid collections, 38 turned out to be sterile. Forty-four of the
patients had scores of 6 or higher, indicating high probability of in-
fection. Among them, 42 patients had truly infected collections.
From the patients with a positive culture, 2 had positive im-
aging findings in regard to gas entrapment and HU greater than 20
but with negative clinical and laboratory parameters (no diabetes and
C-reactive protein, G100 mg/L). Two patients had negative imaging
findings (according to our scoring system) but positive clinical and
laboratory parameters. Vice versa, in the patients with negative cul-
ture, there was 1 patient with negative imaging findings and positive
clinical and laboratory parameters as well as 1 patient with positive
imaging findings and negative clinical and laboratory parameters.
We have to acknowledge the following study limitations. First,
fluid collections may be symptomatic without being infected and are
therefore still requiring intervention. Certainly, our score does not apply
for such situations. Second, this study suffers from inherent limitations
of retrospective study designs. Future studies should evaluate the value
of integrating the score into daily clinical routine in a prospective cohort
of patients. Third, CTexaminations in this study were performed with a
fixed tube potential of 120 kV(p), but the use of recently introduced
automated attenuation-based tube voltage selection algorithms30 would
result in different attenuation measurements and, consequently, in dif-
ferent thresholds for the scoring system. Finally, we used single-energy
but not dual-energy CT, the latter known to improve tissue characteri-
zation in various body regions and applications.31,32
In conclusion, we introduce an objective, easy-to-use scoring
system including quantitative radiologic, laboratory, and clinical in-
formation that helps discriminating infected from noninfected post-
operative fluid collections. This score might be helpful to decide for
the appropriate treatment strategy in patients with postoperative ab-
dominal fluid collections.
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